IRCT201402161760N32已完成未知
The Effect of Letrozole on Symptomatic Uterine Leiomyoma in premenopausal women
Vice Chancellor for Research of Babol University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 42 years（—）
- 性别
- Female
入选标准
- •Premenopausal women aged 42-18 years with a single Intramural leiomyoma size> 5 cm; Women with uterine myoma> 5cm with other myoma size <2cm
- •Exclusion criteria:
- •Other women with myoma size> 2cm; Women with uterine leiomyomas treated with estrogen or progesterone last month; Women with a history of major medical problems or previous medical or surgical treatment for leiomyomas; All women with leiomyoma sizes 2 to 5cm
排除标准
- 未提供
研究者
相似试验
招募中
3 期
the effect of letrozole on endometrial thicknessIRCT20120104008611N14Tehran University of Medical Sciences100
招募中
3 期
Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.Luteinised Follicular CystNCT06244745IVI Madrid152
已完成
2 期
Evaluation of the effect of letrozole on symptomatic uterine leiomyomasterine Liomyoma.Noninflammatory disorder of uterus, unspecifiedIRCT201102015444N2Vice chancellor for Research of Kashan University of Medical Sciences30
尚未招募
不适用
Effects of letrozole in women with endometrioma undergoing ovarian stimulation for in vitro fertilizatioKCT0003374Seoul National University Bundang Hospital80
招募中
1 期
Clinical and endocrinological effects of letrozole during the luteal phase after controlled ovarian stimulation in oocyte donors: a low interventional, randomized, controlled trialCTIS2022-502586-21-00Ivi Madrid S.L.152